Grantham, Mayo, Van Otterloo & Co (GMO)
ABEV icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Ambev ABEV Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ABEV Stock Details ABEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.35M Sell
805,300
-2,300
-0.3% -$6.86K 0.01% 433
2026
Q2 		$2.54M Buy
+807,600
New +$2.52M 0.01% 409
2025
Q3 		– Sell
-2,385,900
Closed -$5.75M – 601
2025
Q2 		$5.75M Buy
2,385,900
+2,367,600
+12,938% +$5.76M 0.02% 279
2025
Q1 		$42.6K Buy
+18,300
New +$36.6K ﹤0.01% 611
2024
Q2 		– Sell
-37,500
Closed -$93K – 527
2024
Q1 		$93K Hold
37,500
– – ﹤0.01% 508
2023
Q4 		$105K Sell
37,500
-20,200
-35% -$54.6K ﹤0.01% 480
2023
Q3 		$149K Buy
57,700
+37,500
+186% +$108K ﹤0.01% 564
2023
Q2 		$64.2K Hold
20,200
– – ﹤0.01% 668
2023
Q1 		$57K Sell
20,200
-88,900
-81% -$233K ﹤0.01% 686
2022
Q4 		$297K Buy
+109,100
New +$318K ﹤0.01% 634
2022
Q2 		– Sell
-196,100
Closed -$633K – 738
2022
Q1 		$633K Sell
196,100
-98,700
-33% -$276K ﹤0.01% 575
2021
Q4 		$825K Buy
+294,800
New +$845K ﹤0.01% 559
2019
Q4 		– Sell
-997,258
Closed -$4.61M – 674
2019
Q3 		$4.61M Buy
997,258
+51,000
+5% +$244K 0.03% 309
2019
Q2 		$4.42M Sell
946,258
-244,700
-21% -$1.1M 0.03% 321
2019
Q1 		$5.12M Sell
1,190,958
-210,100
-15% -$965K 0.04% 268
2018
Q4 		$5.49M Sell
1,401,058
-6,140,700
-81% -$26.2M 0.04% 178
2018
Q3 		$34.5M Buy
7,541,758
+810,958
+12% +$3.87M 0.23% 75
2018
Q2 		$31.2M Buy
+6,730,800
New +$39.5M 0.22% 69
2016
Q4 		– Sell
-16,700
Closed -$102K – 499
2016
Q3 		$102K Sell
16,700
-310,500
-95% -$1.86M ﹤0.01% 492
2016
Q2 		$1.93M Buy
327,200
+96,500
+42% +$518K 0.01% 365
2016
Q1 		$1.2M Sell
230,700
-129,600
-36% -$596K ﹤0.01% 408
2015
Q4 		$1.61M Buy
360,300
+201,200
+126% +$983K 0.01% 348
2015
Q3 		$780K Buy
159,100
+119,700
+304% +$650K ﹤0.01% 428
2015
Q2 		$240K Buy
+39,400
New +$243K ﹤0.01% 426
2014
Q2 		– Sell
-1,944,600
Closed -$14.4M – 490
2014
Q1 		$14.4M Sell
1,944,600
-209,700
-10% -$1.47M 0.04% 176
2013
Q4 		$15.8M Buy
+2,154,300
New +$15.7M 0.04% 167

Other funds holding ABEV

First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
RWC Asset Management
RWC Asset Management London, United Kingdom $2.7B AUM 20.82% 1-Year Est. Return
Private Management Group
Private Management Group Irvine, California $3.63B AUM 11.02% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ABEV Position: Q3 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Ambev (ABEV) stake by 0.28% in Q3 2026, selling an estimated $6.86K and leaving 805,300 shares worth $2.35M. The position accounts for 0.01% of the portfolio, ranked #433.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ABEV in Q4 2013 and has held it in 26 quarters since. The position peaked at $34.5M in Q3 2018. 329 funds tracked by Wall St. Rank hold ABEV as of Q3 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 805,300 shares of Ambev worth $2.35M as of Q3 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 2,300 Ambev shares in Q3 2026, an estimated $6.86K.
  • Ambev made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q3 2026, its #433 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Ambev in Q4 2013 and has held it in 26 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Ambev position peaked at $34.5M in Q3 2018.
  • 329 funds tracked by Wall St. Rank held Ambev as of Q3 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2026, filed 13 Nov 2026.